Pulmonx Corporation (LUNG) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $1.97 (+2.88%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jul 31, 2025 | Jason Bednar | Piper Sandler | $2.50 | +27.2% |
| Oct 31, 2024 | Jason Bednar | Piper Sandler | $10.00 | +408.9% |
| Aug 1, 2024 | William Plovanic | Canaccord Genuity | $16.00 | +714.2% |
| Jun 4, 2024 | Frank Takkinen | Loop Capital Markets | $12.00 | +510.7% |
Top Analysts Covering LUNG
LUNG vs Sector & Market
| Metric | LUNG | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +436.2% | +16186.7% | +19.5% |
| P/E Ratio | -0.94 | 3.79 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $91M | $91M | $91M | 4 |
| 2027-12-31 | $105M | $108M | $111M | 4 |
| 2028-12-31 | $148M | $155M | $174M | 2 |
| 2029-12-31 | $259M | $271M | $304M | 1 |
| 2030-12-31 | $349M | $365M | $409M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.13 | $-1.10 | $-1.07 | 4 |
| 2027-12-31 | $-0.92 | $-0.86 | $-0.78 | 4 |
| 2028-12-31 | $-3.48 | $-0.19 | $3.09 | 2 |
| 2029-12-31 | $1.45 | $1.53 | $1.78 | 1 |
| 2030-12-31 | $2.64 | $2.80 | $3.24 | 1 |
Frequently Asked Questions
What is the analyst consensus for LUNG?
The consensus among 1 analysts covering Pulmonx Corporation (LUNG) is Buy with an average price target of $10.00.
What is the highest price target for LUNG?
The highest price target for LUNG is $16.00, set by William Plovanic at Canaccord Genuity on 2024-08-01.
What is the lowest price target for LUNG?
The lowest price target for LUNG is $2.50, set by Jason Bednar at Piper Sandler on 2025-07-31.
How many analysts cover LUNG?
1 analysts have issued ratings for Pulmonx Corporation in the past 12 months.
Is LUNG a buy or sell right now?
Based on 1 analyst ratings, LUNG has a consensus rating of Buy (2.00/5) with a +436.2% upside to the consensus target of $10.00.
What are the earnings estimates for LUNG?
Analysts estimate LUNG will report EPS of $-1.10 for the period ending 2026-12-31, with revenue estimated at $91M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.